8962
J. Ye et al. / Tetrahedron 69 (2013) 8959e8963
98%), and toluene (3 mL) afforded (R)-4dg (102.5 mg, 39%) (eluant:
petroleum ether) as a colorless liquid: 90% ee (HPLC conditions:
Chiralcel OD-H column, hexane/i-PrOH¼400:1, 0.7 mL/min,
(qd, J1¼7.0 Hz, J2¼2.9 Hz, 2H, CH2),1.53e1.16 (m,12H, CH2ꢂ6), 0.87 (t,
J¼6.6 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3)
¼205.1, 138.1, 135.0,
d
128.4, 127.4, 127.2, 123.7, 95.0, 94.5, 31.9, 29.4, 29.3, 29.20, 29.15, 28.8,
l¼214 nm, tR (major)¼3.9 min, tR (minor)¼4.4 min); [
a]
20 ꢁ220.3 (c
22.7, 21.4, 14.1; MS (EI) m/z (%): 242 (Mþ, 1.03), 91 (100); IR (neat):
D
1.06, CHCl3); 1H NMR (400 MHz, CDCl3)
d
¼7.26 (s, 1H, AreH),
n
¼2955, 2924, 2854, 1949, 1606, 1587, 1488, 1464, 1378 cmꢁ1; HRMS
7.22e7.15 (m, 1H, AreH), 7.15e7.09 (m, 2H, AreH), 6.04 (dt,
J1¼6.4 Hz, J2¼3.0 Hz, 1H, one proton from CH]C]CH), 5.58 (q,
J¼6.7 Hz, 1H, one proton from CH]C]CH), 2.11 (qd, J1¼7.0 Hz,
J2¼2.9 Hz, 2H, CH2), 1.53e1.40 (m, 2H, CH2), 1.40e1.14 (m, 10H,
CH2ꢂ5), 0.87 (t, J¼6.4 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3)
calcd for C18H26 [Mþ]: 242.2035, found: 242.2034.
4.2.9. (R)-1-(4-Trifluoromethylphenyl)undeca-1,2-diene
(R-4dk).
The reaction of ZnBr2 (228.7 mg, 1.0 mmol, 98% from Alfa), 1d
(211.9 mg, 1.5 mmol, 98%), 2k (348.3 mg, 2.0 mmol), (S)-3 (258.4 mg,
1.0 mmol, 98%), and toluene (3 mL) afforded (R)-4dk6 (90.6 mg, 31%)
(eluant: petroleum ether) as a colorless liquid: 95% ee (HPLC con-
ditions: Chiralcel OD-H column, hexane/i-PrOH¼100:0, 0.5 mL/min,
d
¼205.4, 137.2, 134.5, 129.6, 126.5, 126.4, 124.7, 95.6, 93.7, 31.9, 29.4,
29.3, 29.2, 29.1, 28.6, 22.7, 14.1; MS (EI) m/z (%):264 (Mþ(37Cl), 0.66),
262 (Mþ(35Cl), 2.07), 129 (100); IR (neat):
n¼2925, 2854, 1950, 1594,
1571, 1477, 1077 cmꢁ1; HRMS calcd for C17H2335Cl [Mþ]: 262.1488,
found: 262.1486.
l
¼254 nm, tR (minor)¼10.4 min, tR (major)¼11.3 min); [
a
]
20 ꢁ151.7
D
25
(c 1.06, CHCl3) (reported value for 82% ee: [
CHCl3)); H NMR (300 MHz, CDCl3)
a]
ꢁ142.5 (c 0.55,
D
1
d¼7.53 (d, J¼8.1 Hz, 2H, AreH),
4.2.6. (R)-1-(4-Fluorophenyl)undeca-1,2-diene (R-4dh). The re-
action of ZnBr2 (229.9 mg, 1.0 mmol, 98% from Alfa), 1d (211.7 mg,
1.5 mmol, 98%), 2h (249.1 mg, 2.0 mmol), (S)-3 (259.3 mg,1.0 mmol,
98%), and toluene (3 mL) afforded (R)-4dh6 (116.7 mg, 47%) (eluant:
petroleum ether) as a colorless liquid: 92% ee (HPLC conditions:
Chiralcel OJ-H column, hexane/i-PrOH¼100:0, 0.6 mL/min,
7.37 (d, J¼8.4 Hz, 2H, AreH), 6.14 (dt, J1¼6.3 Hz, J2¼3.1 Hz, 1H, one
proton from CH]C]CH), 5.62 (q, J¼6.7 Hz, 1H, one proton from
CH]C]CH), 2.14 (qd, J1¼7.1 Hz, J2¼3.0 Hz, 2H, CH2), 1.54e1.15 (m,
12H, CH2ꢂ6), 0.87 (t, J¼6.6 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3)
d
¼206.1, 139.1 (d, J¼1.5 Hz), 128.4 (q, J¼32.2 Hz), 126.6, 125.4 (q,
J¼3.9 Hz), 124.3 (q, J¼270.0 Hz), 95.7, 93.8, 31.8, 29.4, 29.3, 29.2, 29.1,
l
¼214 nm, tR (major)¼8.2 min, tR (minor)¼9.4 min); [
a
]
23 ꢁ180.8 (c
28.5, 22.7, 14.1; 19F NMR (282 MHz, CDCl3)
d
¼ꢁ63.0; MS (EI) m/z (%):
D
25
1.00, CHCl3) (reported value for 90% ee: [
a
]
ꢁ146.5 (c 0.50,
296 (Mþ, 1.15), 129 (100); IR (neat):
n
¼2927, 2856, 1950, 1616, 1467,
D
CHCl3)); 1H NMR (300 MHz, CDCl3)
d¼7.27e7.17 (m, 2H, AreH), 6.97
1324, 1164, 1124, 1066, 1017 cmꢁ1; HRMS calcd for C18H23F3 [Mþ]:
296.1752, found: 296.1756.
(t, J¼8.7 Hz, 2H, AreH), 6.08 (dt, J1¼6.3 Hz, J2¼3.0 Hz, 1H, one
proton from CH]C]CH), 5.55 (q, J¼6.7 Hz, 1H, one proton from
CH]C]CH), 2.11 (qd, J1¼7.0 Hz, J2¼2.9 Hz, 2H, CH2), 1.53e1.13 (m,
12H, CH2ꢂ6), 0.87 (t, J¼6.3 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3)
4.2.10. (R)-1-(3-Methoxyphenyl)undeca-1,2-diene (R-4dl). The re-
action of ZnBr2 (230.9 mg, 1.0 mmol, 98% from Alfa), 1d (212.0 mg,
1.5 mmol, 98%), 2l (272.2 mg, 2.0 mmol), (S)-3 (258.3 mg, 1.0 mmol,
98%), and toluene (3 mL) afforded (R)-4dl6 (126.6 mg, 49%) (eluant:
petroleum ether) as a colorless liquid: 94% ee (HPLC conditions:
Chiralcel OD-H column, hexane/i-PrOH¼100:1, 0.6 mL/min,
d
¼204.9 (d, J¼1.7 Hz),161.7 (d, J¼243.2 Hz),131.1 (d, J¼3.2 Hz),127.9
(d, J¼8.6 Hz), 115.4 (d, J¼21.8 Hz), 95.3, 93.6, 31.9, 29.4, 29.3, 29.2,
29.1, 28.8, 22.7, 14.1; 19F NMR (282 MHz, CDCl3)
d¼ꢁ116.4; MS (EI)
m/z (%): 246 (Mþ, 3.44), 175 (MþꢁC5H11, 3.77), 148 (100); IR (neat):
n
¼2926, 2855, 1950, 1599, 1509, 1230, 1156 cmꢁ1; HRMS calcd for
l
¼214 nm, tR (major)¼6.4 min, tR (minor)¼7.3 min); [
a
]
19 ꢁ209.1 (c
D
25
C17H23F [Mþ]: 246.1784, found: 246.1787.
1.00, CHCl3) (reported value for 94% ee: [
a
]
ꢁ193.5 (c 0.33,
D
CHCl3)); 1H NMR (400 MHz, CDCl3)
d¼7.21 (t, J¼7.8 Hz, 1H, AreH),
4.2.7. (R)-1-(4-Methylphenyl)undeca-1,2-diene (R-4di). The re-
action of ZnBr2 (229.5 mg, 1.0 mmol, 98% from Alfa), 1d (212.1 mg,
1.5 mmol, 98%), 2i (240.1 mg, 2.0 mmol), (S)-3 (258.3 mg, 1.0 mmol,
98%), and toluene (3 mL) afforded (R)-4di6 (78.6 mg, 32%) (eluant:
petroleum ether) as a colorless liquid: 94% ee (HPLC conditions:
Chiralcel OD-H column, hexane/i-PrOH¼100:0, 0.7 mL/min,
6.91e6.83 (m, 2H, AreH), 6.74 (dd, J1¼8.0 Hz, J2¼2.4 Hz, 1H, AreH),
6.09 (dt, J1¼6.4 Hz, J2¼3.0 Hz, 1H, one proton from CH]C]CH),
5.56 (q, J¼6.7 Hz, 1H, one proton from CH]C]CH), 3.80 (s, 3H,
OCH3), 2.12 (qd, J1¼7.1 Hz, J2¼2.8 Hz, 2H, CH2), 1.53e1.16 (m, 12H,
CH2ꢂ6), 0.87 (t, J¼6.8 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3)
d
¼205.2, 159.8, 136.6, 129.4, 119.2, 112.3, 111.7, 95.2, 94.5, 55.1, 31.8,
l
¼254 nm, tR (major)¼9.8 min, tR (minor)¼11.3 min); [
a
]
15 ꢁ221.9 (c
29.4, 29.3, 29.19, 29.15, 28.7, 22.7, 14.1; MS (EI) m/z (%): 258 (Mþ,
D
1.03, CHCl3) (reported value for 90% ee: [
a]
D
25 ꢁ151.5 (c 0.51, CHCl3));
3.83), 160 (100); IR (neat):
n
¼2925, 2854, 1950, 1598, 1490, 1466,
1H NMR (300 MHz, CDCl3)
d¼7.18 (d, J¼7.8 Hz, 2H, AreH), 7.10 (d,
1155, 1087, 1047 cmꢁ1; HRMS calcd for C18H26O [Mþ]: 258.1984,
found: 258.1985.
J¼7.8 Hz, 2H, AreH), 6.09 (dt, J1¼6.3 Hz, J2¼2.9 Hz, 1H, one proton
from CH]C]CH), 5.54 (q, J¼6.5 Hz, 1H, one proton from CH]C]
CH), 2.32 (s, 3H, CH3), 2.11 (qd, J1¼6.9 Hz, J2¼2.5 Hz, 2H, CH2),
1.53e1.16 (m, 12H, CH2ꢂ6), 0.87 (t, J¼6.3 Hz, 3H, CH3); 13C NMR
4.2.11. (R)-1-Phenyltrideca-1,2-diene (R-4bb). The reaction of ZnBr2
(229.3 mg, 1.0 mmol, 98% from Alfa), 1b (257.3 mg, 1.5 mmol, 98%),
2b (212.5 mg, 2.0 mmol), (S)-3 (259.4 mg, 1.0 mmol, 98%), and
toluene (3 mL) afforded (R)-4bb4c (117.9 mg, 46%) (eluant: petro-
leum ether) as a colorless liquid: 93% ee (HPLC conditions: Chiralcel
(75 MHz, CDCl3)
d¼204.8, 136.2, 132.1, 129.2, 126.4, 95.0, 94.3, 31.9,
29.4, 29.3, 29.20, 29.17, 28.8, 22.7, 21.1, 14.1; MS (EI) m/z (%): 242 (Mþ,
1.26), 129 (100); IR (neat):
n
¼2955, 2924, 2854, 1949, 1513,
1465 cmꢁ1; HRMS calcd for C18H26 [Mþ]: 242.2035, found: 242.2037.
OD-H column, hexane/i-PrOH¼100:0, 1.0 mL/min,
l
¼214 nm, tR
(major)¼6.2 min, tR (minor)¼6.8 min); [
a
]
26 ꢁ183.5 (c 0.94, CHCl3)
D
20
4.2.8. (R)-1-(3-Methylphenyl)undeca-1,2-diene (R-4dj). The re-
action of ZnBr2 (230.1 mg, 1.0 mmol, 98% from Alfa), 1d (211.7 mg,
1.5 mmol, 98%), 2j (240.9 mg, 2.0 mmol), (S)-3 (258.6 mg, 1.0 mmol,
98%), and toluene (3 mL) afforded (R)-4dj6 (105.6 mg, 44%) (eluant:
petroleum ether) as a colorless liquid: 92% ee (HPLC conditions:
Chiralcel OD-H column, hexane/i-PrOH¼100:0, 0.7 mL/min,
(reported value for 95% ee: [
(300 MHz, CDCl3)
a]
ꢁ181.6 (c 1.05, CHCl3)); 1H NMR
D
d
¼7.34e7.26 (m, 4H, AreH), 7.22e7.13 (m, 1H,
AreH), 6.12 (dt, J1¼6.6 Hz, J2¼3.1 Hz, 1H, one proton from CH]C]
CH), 5.56 (q, J¼6.7 Hz, 1H, one proton from CH]C]CH), 2.12 (qd,
J1¼7.1 Hz, J2¼3.0 Hz, 2H, CH2), 1.54e1.15 (m, 16H, CH2ꢂ8), 0.88 (t,
J¼6.6 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3)
¼205.1, 135.1, 128.5,
d
l
¼254 nm, tR (major)¼10.3 min, tR (minor)¼11.8 min); [
a
]
20 ꢁ194.9
126.5, 95.1, 94.5, 31.9, 29.64, 29.60, 29.4, 29.3, 29.19, 29.17, 28.8,
22.7, 14.1.
D
25
(c 1.02, CHCl3) (reported value for 90% ee: [
a]
ꢁ125.3 (c 0.50,
D
CHCl3)); 1H NMR (300 MHz, CDCl3)
d¼7.23e7.14 (m, 1H, AreH),
7.14e7.05 (m, 2H, AreH), 6.99 (d, J¼7.2 Hz, 1H, AreH), 6.08 (dt,
J1¼6.3 Hz, J2¼3.0 Hz, 1H, one proton from CH]C]CH), 5.54 (q,
J¼6.6 Hz, 1H, one proton from CH]C]CH), 2.33 (s, 3H, CH3), 2.12
4.2.12. (R)-3-Cyclohexyl-1-phenyl-1,2-propadiene (R-4eb). The re-
action of ZnBr2 (229.3 mg, 1.0 mmol, 98% from Alfa), 1e (165.8 mg,
1.5 mmol, 98%), 2b (212.6 mg, 2.0 mmol), (S)-3 (259.5 mg, 1.0 mmol,